Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Xiangyang Chi

Showing results (31-40 of 35) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 35 results.
Cell Discovery|December 9, 2022
A bispecific nanobody dimer broadly neutralizes SARS-CoV-1 & 2 variants of concern and offers substantial protection against Omicron via low-dose intranasal administrationHuan Ma, Xinghai Zhang, Weihong Zeng, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|April 29, 2025
Potent Cross-neutralizing Antibodies Reveal Vulnerabilities of Henipavirus Fusion GlycoproteinYi Ren, Pengfei Fan, Xinghai Zhang, et al.
Science (New York, N.Y.)|June 24, 2020
A neutralizing human antibody binds to the N-terminal domain of the Spike protein of SARS-CoV-2Xiangyang Chi, Renhong Yan, Jun Zhang, et al.
Nature Communications|May 21, 2024
A potent Henipavirus cross-neutralizing antibody reveals a dynamic fusion-triggering pattern of the G-tetramerPengfei Fan, Mengmeng Sun, Xinghai Zhang, et al.
Signal Transduction and Targeted Therapy|April 28, 2022
Broadly neutralizing antibodies against Omicron-included SARS-CoV-2 variants induced by vaccinationXiangyang Chi, Yingying Guo, Guanying Zhang, et al.
Pageof 4

Showing results (31-40 of 35) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 35 results.
Cell Discovery|December 9, 2022
A bispecific nanobody dimer broadly neutralizes SARS-CoV-1 & 2 variants of concern and offers substantial protection against Omicron via low-dose intranasal administrationHuan Ma, Xinghai Zhang, Weihong Zeng, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|April 29, 2025
Potent Cross-neutralizing Antibodies Reveal Vulnerabilities of Henipavirus Fusion GlycoproteinYi Ren, Pengfei Fan, Xinghai Zhang, et al.
Science (New York, N.Y.)|June 24, 2020
A neutralizing human antibody binds to the N-terminal domain of the Spike protein of SARS-CoV-2Xiangyang Chi, Renhong Yan, Jun Zhang, et al.
Nature Communications|May 21, 2024
A potent Henipavirus cross-neutralizing antibody reveals a dynamic fusion-triggering pattern of the G-tetramerPengfei Fan, Mengmeng Sun, Xinghai Zhang, et al.
Signal Transduction and Targeted Therapy|April 28, 2022
Broadly neutralizing antibodies against Omicron-included SARS-CoV-2 variants induced by vaccinationXiangyang Chi, Yingying Guo, Guanying Zhang, et al.
Pageof 4